Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
912.00    16.00 (1.79%)
Bid:
911.00
Ask:
912.00
Spread: 1.00 (0.11%)
Market Cap: £131.21b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

AT1s Contingent Convertible securities

30 Jul 2024 07:00

RNS Number : 2944Y
Banco Santander S.A.
29 July 2024
 

Banco Santander, S.A. ("Banco Santander" or the "Bank"), in compliance with the Securities Market legislation, hereby announces the following:

 

OTHER RELEVANT INFORMATION

Banco Santander announces that it has completed the placement of preferred securities contingently convertible into newly issued ordinary shares of the Bank, excluding the pre-emptive subscription rights of its shareholders and for a total nominal amount of one billion five hundred million U.S. dollars ($ 1,500,000,000) (the "Issue" and the "CoCos").

The placement of the Issue has been carried out through an accelerated book-building targeted at professional investors and eligible counterparties only.

The CoCos are issued at par and its remuneration, the payment of which is subject to certain conditions and to the discretion of the Bank, has been set at 8.000% on an annual basis for the first 10 years, which will be reviewed every five years thereafter, in accordance with the terms and conditions of the CoCos, by applying a margin of 391.1 basis points to the rate resulting from the applicable 5-year UST.

Once issued, the CoCos will be eligible as additional tier 1 capital of Banco Santander in accordance with Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms ("CRR"). The CoCos are perpetual, but they may be called under certain circumstances and would be converted into newly issued ordinary shares of Banco Santander if the common equity tier 1 (CET1) ratio of the Bank or its consolidated group, calculated in accordance with CRR, were to fall below 5.125%. As of 30 June 2024, the fully loaded consolidated CET1 ratio of the Bank was 12.5%.

The Bank will request the admission of the CoCos to trading on the New York Stock Exchange.

The Bank also announces that, as of today, the report of the directors of the Bank concerning the basis and rules for the conversion of the CoCos and the exclusion of pre‑emptive subscription rights, issued in accordance with articles 414.2, 417.2 and 510 of the Spanish Companies Act (Ley de Sociedades de Capital), will be available on the Bank's website (www.santander.com). The aforementioned report will also be provided to the shareholders at the first general shareholders' meeting to be held after the Issue.

 

Boadilla del Monte (Madrid), 29 July 2024

IMPORTANT INFORMATION

This other relevant information notice does not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of such securities in any state of the United States or in any other jurisdiction in which such offer, solicitation or sale would not be permitted before registration or qualification under the securities laws of such state or jurisdiction. This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

No action has been made or will be taken that would permit a public offering of any securities described herein in any jurisdiction in which action for that purpose is required. No offers, sales, resales or delivery of any securities described herein or distribution of any offering material relating to any such securities may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations and which will not impose any obligation on the Bank or the underwriters of the Issue or any of their respective affiliates.

In connection with the Issue of the CoCos, the Bank has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents the Bank has filed with the SEC for more complete information about the Bank and the offer of the CoCos. You may obtain these documents for free by visiting the SEC's web site at www.sec.gov.

This other relevant information notice is an announcement and not a prospectus, and investors should not subscribe for or purchase any securities referred to herein except on the basis of the information included in the prospectus and the prospectus supplement and the other documents filed by the Bank with the SEC that are incorporated by reference in the registration statement.

This other relevant information notice does not constitute an offer document or an offer of transferable securities to the public in the United Kingdom in accordance with the Financial Services and Markets Act 2000 ("FSMA") and should not be considered as a recommendation that any person should subscribe for or purchase any of the securities described herein. These securities will not be offered or sold to any person in the United Kingdom except in circumstances which have not resulted and will not result in an offer to the public in the United Kingdom in contravention of the FSMA.

This other relevant information notice does not constitute an offer to the public in Italy of financial products, as defined under legislative decree no. 58 of 24 February 1998, as amended (the "Financial Services Act"). The offering of the preferred securities has not been registered with the Commissione Nazionale per le Società e la Borsa ("CONSOB") pursuant to Italian securities legislation and, accordingly, the securities described herein may not be offered, sold or delivered, nor any copies of the prospectus, the prospectus supplement or of any other document relating to the preferred securities be distributed in Italy, except: (a) to qualified investors (investitori qualificati), as defined pursuant to Article 2 of the Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the "Prospectus Regulation") and any other applicable regulation of the Financial Services Act and the Italian CONSOB Regulation ("CONSOB Regulation"); or (b) in any other circumstances which are exempted from the rules on public offerings pursuant to Article 1 of the Prospectus Regulation, Article 100 of the Financial Services Act, Article 34ter of the CONSOB Regulation No. 11971 of 14 May 1999, as amended from time to time, and the applicable Italian laws.

The offer, sale or distribution of CoCos, as well as any subsequent resale, cannot be carried out in Spain unless it complies with all legal and regulatory requirements under Spanish securities laws or in circumstances that do not require the registration of a prospectus in Spain.

This other relevant information notice is for information purposes only and does not constitute and shall not, in any circumstances, constitute a public offering or an invitation to the public in connection with any offer within the meaning of the Prospectus Regulation.

As set out in the CoCos' prospectus and prospectus supplement, there are further restrictions in different jurisdictions, including Canada, the European Economic Area, United Kingdom, Hong Kong, Italy, Japan, the People's Republic of China, Republic of Korea, Taiwan, Singapore, Switzerland and Australia.

Restrictions on marketing and sale and resale to retail investors

The CoCos are not intended to be offered, sold or otherwise made available and should not be offered, sold or otherwise made available to retail clients (as defined in Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on Markets in Financial Instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II), as amended or replaced from time to time, and Regulation (EU) 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act of 2018 (EUWA)). Prospective investors are referred to the section headed "Important Information" of the prospectus supplement for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODPPUQCMUPCPGB
Date   Source Headline
11th Jun 202611:02 amRNSBuyback programme: transactions 4-10June
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb
18th Feb 20264:48 pmRNSDirector/PDMR Shareholding
18th Feb 202611:07 amRNSInvestor Day meeting announcement
12th Feb 20263:02 pmRNSBuyback programme: transactions 4-11Feb
10th Feb 20265:09 pmRNSChanges to the presentation of Group’s information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.